SEC Comment Letter for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686) (TEVA) — Jun 25, 2007
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA, TEVJF) (CIK 0000818686)
Date: June 25, 2007 · CIK: 0000818686 · Accession: 0000000000-07-031027
AI Filing Summary & Sentiment
File numbers found in text: 000-16174
Letter
Via Facsimile and U.S. Mail Mail Stop 6010 June 25, 2007 Dan S. Suesskind Chief Financial Officer Teva Pharmaceutical Industries Limited 5 Basel Street P.O. Box 3190 Petach Tikva 49131, Israel
Re: Teva Pharmaceutical Industries Limited Form 20-F for Fiscal Year Ended December 31, 2006 File No. 000-16174
Dear Mr. Suesskind:
We have completed our review of your Form 20-F and have no further comments at this time.
S i n c e r e l y ,
J i m A t k i n s o n A c c o u n t i n g B r a n c h C h i e f
Show Raw Text
Via Facsimile and U.S. Mail
Mail Stop 6010
June 25, 2007
Dan S. Suesskind
Chief Financial Officer
Teva Pharmaceutical Industries Limited
5 Basel Street
P.O. Box 3190
Petach Tikva 49131, Israel
Re: Teva Pharmaceutical Industries Limited
Form 20-F for Fiscal Year Ended December 31, 2006
File No. 000-16174
Dear Mr. Suesskind:
We have completed our review of your Form 20-F and have no further comments
at this time.
S i n c e r e l y ,
J i m A t k i n s o n
A c c o u n t i n g B r a n c h C h i e f